FDA Drug Application (018647) for CORZIDE by KING PHARMS

Back to FDA Applications sponsored by KING PHARMS

Application Number018647
Product Number001
FormTABLET;ORAL
Dosage5MG;40MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameCORZIDE
Active IngredientBENDROFLUMETHIAZIDE; NADOLOL

Active IngredientCount
List of drugs with Active Ingredient BENDROFLUMETHIAZIDE5
List of drugs with Active Ingredient NADOLOL4


Back to FDA Applications sponsored by KING PHARMS